October 4, 2023 12:41 PM EDT
Pharma

San­doz shares dip on first day of Swiss list­ing af­ter No­var­tis spin­off

Ayisha Sharma

News Reporter

No­var­tis has com­plet­ed a spin­off of its gener­ics and biosim­i­lars arm San­doz, which made its de­but ear­li­er to­day on the SIX …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
ENDPOINTS CAREERS

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA

TRENDING NOW

Se­cre­tive Tree­line Bio­sciences dis­clos­es $421M fi­nanc­ing in fil­ing

Benev­o­len­tAI CEO is out af­ter less than a year on the job

FDA ap­proves Ab­b­Vie's 24-hour Parkin­son's in­fu­sion ther­a­py af­ter two CRLs

House’s promi­nent Chi­na crit­ic Jim Mc­Gov­ern leads op­po­si­tion to Biose­cure Act: ‘I would pre­fer to go back to the ...

Mer­ck KGaA eyes more man­u­fac­tur­ing M&A as it faces head­winds in Chi­na

sponsored

Join the Gen­Script Biotech Glob­al Fo­rum: Un­lock­ing In­no­va­tions in Cell and Gene Ther­a­pies

A service from the Financial Times